Application of remote home respiratory rehabilitation for pneumoconiosis_West China Medical Journal

Authors：

CHEN Xiaobing ¹ , WU Di ¹ , WANG Lianchang ¹ , CHANG Yuwen ¹ , TAN Caiju ¹ , HE Jian ¹ ,  YIN Zhifei ^1,2

1. School of Rehabilitation Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, P. R. China;
2. Center of Rehabilitation Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P. R. China;

Corresponding?author：

YIN Zhifei, Email: feifei44881@sina.com

Keywords：

Pneumoconiosis; remote home-based rehabilitation; respiratory rehabilitation; exercise

DOI：

10.7507/1002-0179.202210100

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Pneumoconiosis is an interstitial lung disease with pulmonary fibrosis as the main pathological change. Patients with pneumoconiosis can increase immunity, delay disease progression, reduce symptoms, and improve lung function through respiratory rehabilitation. With the development of the domestic medical stratification, grading, and referral system between various specialties and the promotion of “internet +” model, remote home respiratory rehabilitation has become an inevitable trend in the full-cycle management of chronic respiratory diseases. By searching Chinese and English literatures, this article summarizes the safety, efficacy and research progress of remote home respiratory rehabilitation for pneumoconiosis. The purpose is to provide ideas for patients with pneumoconiosis to receive home-based remote rehabilitation management.

Citation： CHEN Xiaobing, WU Di, WANG Lianchang, CHANG Yuwen, TAN Caiju, HE Jian, YIN Zhifei. Application of remote home respiratory rehabilitation for pneumoconiosis. West China Medical Journal, 2023, 38(1): 111-115. doi: 10.7507/1002-0179.202210100 Copy

1.	Zhao H, Xie Y, Wang J, et al. Pulmonary rehabilitation for pneumoconiosis: protocol for a systematic review and meta-analysis. BMJ Open, 2019, 9(8): e025891.
2.	Li J, Yin P, Wang H, et al. The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019. BMC Public Health, 2022, 22(1): 1114.
3.	Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med, 2013, 188(8): e13-e64.
4.	Hanada M, Sakamoto N, Ishimoto H, et al. A comparative study of the sarcopenia screening in older patients with interstitial lung disease. BMC Pulm Med, 2022, 22(1): 45.
5.	世界中醫藥學會聯合會肺康復專業委員會, 呼吸疾病中醫藥防治省部共建協同創新中心, 河南中醫藥大學. 塵肺病康復專家共識(2021 版). 中國循證醫學雜志, 2021, 21(9): 1000-1007.
6.	中國醫師協會呼吸醫師分會, 中華醫學會呼吸病學分會, 中國康復醫學會呼吸康復專業委員會, 等. 中國慢性呼吸道疾病呼吸康復管理指南(2021 年). 中華健康管理學雜志, 2021, 15(6): 521-538.
7.	Singh S, Sharma BB, Bairwa M, et al. Management of interstitial lung diseases: a consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP). Lung India, 2020, 37(4): 359-378.
8.	Wen J, Milne S, Sin DD. Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions. Curr Opin Pulm Med, 2022, 28(2): 152-161.
9.	Vanka KS, Shukla S, Gomez HM, et al. Understanding the pathogenesis of occupational coal and silica dust-associated lung disease. Eur Respir Rev, 2022, 31(165): 210250.
10.	Quan H, Wu W, Yang G, et al. Risk factors of silicosis progression: a retrospective cohort study in China. Front Med (Lausanne), 2022, 9: 832052.
11.	Nakazawa A, Cox NS, Holland AE. Current best practice in rehabilitation in interstitial lung disease. Ther Adv Respir Dis, 2017, 11(2): 115-128.
12.	Molgat-Seon Y, Guler SA, Peters CM, et al. Pectoralis muscle area and its association with indices of disease severity in interstitial lung disease. Respir Med, 2021, 186: 106539.
13.	Mendoza L, Gogali A, Shrikrishna D, et al. Quadriceps strength and endurance in fibrotic idiopathic interstitial pneumonia. Respirology, 2014, 19(1): 138-143.
14.	Philippova A, Aringazina R, Kurmanalina G, et al. Epidemiology, clinical and physiological manifestations of dust lung disease in major industrial centers. Emerg Themes Epidemiol, 2022, 19(1): 3.
15.	Jenkins AR, Gowler H, Curtis F, et al. Efficacy of supervised maintenance exercise following pulmonary rehabilitation on health care use: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis, 2018, 13: 257-273.
16.	Zhao H, Xie Y, Wang J, et al. Pulmonary rehabilitation can improve the functional capacity and quality of life for pneumoconiosis patients: a systematic review and meta-analysis. Biomed Res Int, 2020, 2020: 6174936.
17.	Halabchi F, Alizadeh Z, Sahraian MA, et al. Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations. BMC Neurol, 2017, 17(1): 185.
18.	Li X, Yu R, Wang P, et al. Effects of exercise training on cardiopulmonary function and quality of life in elderly patients with pulmonary fibrosis: a meta-analysis. Int J Environ Res Public Health, 2021, 18(14): 7643.
19.	Dowman LM, McDonald CF, Hill CJ, et al. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax, 2017, 72(7): 610-619.
20.	Essam H, Abdel Wahab NH, Younis G, et al. Effects of different exercise training programs on the functional performance in fibrosing interstitial lung diseases: a randomized trial. PLoS One, 2022, 17(5): e0268589.
21.	Oldenburger A, Teschler H, Teschler S, et al. Effects of outpatient compact rehabilitation on physical performance and quality of life in patients with work-related lung diseases. Pneumologie, 2022, 76(1): 35-46.
22.	Fekete M, Fazekas-Pongor V, Balazs P, et al. Role of new digital technologies and telemedicine in pulmonary rehabilitation: smart devices in the treatment of chronic respiratory diseases. Wien Klin Wochenschr, 2021, 133(21/22): 1201-1207.
23.	Stuart T, Hanna J, Gutruf P. Wearable devices for continuous monitoring of biosignals: challenges and opportunities. APL Bioeng, 2022, 6(2): 021502.
24.	Holland AE, Malaguti C, Hoffman M, et al. Home-based or remote exercise testing in chronic respiratory disease, during the COVID-19 pandemic and beyond: a rapid review. Chron Respir Dis, 2020, 17: 1479973120952418.
25.	Motta LP, Silva PPFD, Borguezan BM, et al. An emergency system for monitoring pulse oximetry, peak expiratory flow, and body temperature of patients with COVID-19 at home: development and preliminary application. PLoS One, 2021, 16(3): e0247635.
26.	McNamara RJ, Dale M, McKeough ZJ. Innovative strategies to improve the reach and engagement in pulmonary rehabilitation. J Thorac Dis, 2019, 11(Suppl 17): S2192-S2199.
27.	Moor CC, van Leuven SI, Wijsenbeek MS, et al. Feasibility of online home spirometry in systemic sclerosis-associated interstitial lung disease: a pilot study. Rheumatology (Oxford), 2021, 60(5): 2467-2471.
28.	Li J, Li X, Deng M, et al. Features and predictive value of 6-min walk test outcomes in interstitial lung disease: an observation study using wearable monitors. BMJ Open, 2022, 12(6): e055077.
29.	Moor CC, Mostard RLM, Grutters JC, et al. Home monitoring in patients with idiopathic pulmonary fibrosis. A randomized controlled trial. Am J Respir Crit Care Med, 2020, 202(3): 393-401.
30.	Attaway AH, Welch N, Yadav R, et al. Quantitative computed tomography assessment of pectoralis and erector spinae muscle area and disease severity in chronic obstructive pulmonary disease referred for lung volume reduction. COPD, 2021, 18(2): 191-200.
31.	Y?lmaz ?ankaya B, Karaman A, et al. The association of silicosis severity with pectoralis major muscle and subcutaneous fat volumes and the pulmonary artery/aorta ratio evaluated by CT. Diagn Interv Radiol, 2021, 27(1): 37-41.
32.	Tsang EW, Kwok H, Chan AKY, et al. Outcomes of community-based and home-based pulmonary rehabilitation for pneumoconiosis patients: a retrospective study. BMC Pulm Med, 2018, 18(1): 133.
33.	程樂霞, 李萍, 米正萍. 基于 Heider 平衡理論的遠程教育干預在塵肺病患者中的應用效果分析. 工業衛生與職業病, 2021, 47(2): 110-113.
34.	彭秋鳳, 何靜春, 李立宇, 等. 遠程指導運動呼吸訓練在穩定期Ⅱ期塵肺病患者中的實施效果觀察. 山東醫藥, 2022, 62(33): 64-67.
35.	Layton AM, Irwin AM, Mihalik EC, et al. Telerehabilitation using fitness application in patients with severe cystic fibrosis awaiting lung transplant: a pilot study. Int J Telemed Appl, 2021, 2021: 6641853.
36.	Dechman G, Aceron R, Beauchamp M, et al. Delivering pulmonary rehabilitation during the COVID-19 pandemic: a Canadian Thoracic Society position statement. Can J Resp Crit Care, 2020, 4(4): 232-235.
37.	Geramita EM, DeVito Dabbs AJ, DiMartini AF, et al. Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial. Transplantation, 2020, 104(3): 640-651.
38.	K?l?? L, Pehlivan E, Balc? A, et al. Effect of 8-week pulmonary rehabilitation program on dyspnea and functional capacity of patients on waiting list for lung transplantation. Turk Thorac J, 2020, 21(2): 110-115.
39.	Wickerson L, Helm D, Gottesman C, et al. Telerehabilitation for lung transplant candidates and recipients during the COVID-19 pandemic: program evaluation. JMIR Mhealth Uhealth, 2021, 9(6): e28708.
40.	Dowman L, Hill CJ, May A, et al. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev, 2021, 2(2): CD006322.
41.	Cox NS, Dal Corso S, Hansen H, et al. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev, 2021, 1(1): CD013040.

1. Zhao H, Xie Y, Wang J, et al. Pulmonary rehabilitation for pneumoconiosis: protocol for a systematic review and meta-analysis. BMJ Open, 2019, 9(8): e025891.
2. Li J, Yin P, Wang H, et al. The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019. BMC Public Health, 2022, 22(1): 1114.
3. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med, 2013, 188(8): e13-e64.
4. Hanada M, Sakamoto N, Ishimoto H, et al. A comparative study of the sarcopenia screening in older patients with interstitial lung disease. BMC Pulm Med, 2022, 22(1): 45.
5. 世界中醫藥學會聯合會肺康復專業委員會, 呼吸疾病中醫藥防治省部共建協同創新中心, 河南中醫藥大學. 塵肺病康復專家共識(2021 版). 中國循證醫學雜志, 2021, 21(9): 1000-1007.
6. 中國醫師協會呼吸醫師分會, 中華醫學會呼吸病學分會, 中國康復醫學會呼吸康復專業委員會, 等. 中國慢性呼吸道疾病呼吸康復管理指南(2021 年). 中華健康管理學雜志, 2021, 15(6): 521-538.
7. Singh S, Sharma BB, Bairwa M, et al. Management of interstitial lung diseases: a consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP). Lung India, 2020, 37(4): 359-378.
8. Wen J, Milne S, Sin DD. Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions. Curr Opin Pulm Med, 2022, 28(2): 152-161.
9. Vanka KS, Shukla S, Gomez HM, et al. Understanding the pathogenesis of occupational coal and silica dust-associated lung disease. Eur Respir Rev, 2022, 31(165): 210250.
10. Quan H, Wu W, Yang G, et al. Risk factors of silicosis progression: a retrospective cohort study in China. Front Med (Lausanne), 2022, 9: 832052.
11. Nakazawa A, Cox NS, Holland AE. Current best practice in rehabilitation in interstitial lung disease. Ther Adv Respir Dis, 2017, 11(2): 115-128.
12. Molgat-Seon Y, Guler SA, Peters CM, et al. Pectoralis muscle area and its association with indices of disease severity in interstitial lung disease. Respir Med, 2021, 186: 106539.
13. Mendoza L, Gogali A, Shrikrishna D, et al. Quadriceps strength and endurance in fibrotic idiopathic interstitial pneumonia. Respirology, 2014, 19(1): 138-143.
14. Philippova A, Aringazina R, Kurmanalina G, et al. Epidemiology, clinical and physiological manifestations of dust lung disease in major industrial centers. Emerg Themes Epidemiol, 2022, 19(1): 3.
15. Jenkins AR, Gowler H, Curtis F, et al. Efficacy of supervised maintenance exercise following pulmonary rehabilitation on health care use: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis, 2018, 13: 257-273.
16. Zhao H, Xie Y, Wang J, et al. Pulmonary rehabilitation can improve the functional capacity and quality of life for pneumoconiosis patients: a systematic review and meta-analysis. Biomed Res Int, 2020, 2020: 6174936.
17. Halabchi F, Alizadeh Z, Sahraian MA, et al. Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations. BMC Neurol, 2017, 17(1): 185.
18. Li X, Yu R, Wang P, et al. Effects of exercise training on cardiopulmonary function and quality of life in elderly patients with pulmonary fibrosis: a meta-analysis. Int J Environ Res Public Health, 2021, 18(14): 7643.
19. Dowman LM, McDonald CF, Hill CJ, et al. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax, 2017, 72(7): 610-619.
20. Essam H, Abdel Wahab NH, Younis G, et al. Effects of different exercise training programs on the functional performance in fibrosing interstitial lung diseases: a randomized trial. PLoS One, 2022, 17(5): e0268589.
21. Oldenburger A, Teschler H, Teschler S, et al. Effects of outpatient compact rehabilitation on physical performance and quality of life in patients with work-related lung diseases. Pneumologie, 2022, 76(1): 35-46.
22. Fekete M, Fazekas-Pongor V, Balazs P, et al. Role of new digital technologies and telemedicine in pulmonary rehabilitation: smart devices in the treatment of chronic respiratory diseases. Wien Klin Wochenschr, 2021, 133(21/22): 1201-1207.
23. Stuart T, Hanna J, Gutruf P. Wearable devices for continuous monitoring of biosignals: challenges and opportunities. APL Bioeng, 2022, 6(2): 021502.
24. Holland AE, Malaguti C, Hoffman M, et al. Home-based or remote exercise testing in chronic respiratory disease, during the COVID-19 pandemic and beyond: a rapid review. Chron Respir Dis, 2020, 17: 1479973120952418.
25. Motta LP, Silva PPFD, Borguezan BM, et al. An emergency system for monitoring pulse oximetry, peak expiratory flow, and body temperature of patients with COVID-19 at home: development and preliminary application. PLoS One, 2021, 16(3): e0247635.
26. McNamara RJ, Dale M, McKeough ZJ. Innovative strategies to improve the reach and engagement in pulmonary rehabilitation. J Thorac Dis, 2019, 11(Suppl 17): S2192-S2199.
27. Moor CC, van Leuven SI, Wijsenbeek MS, et al. Feasibility of online home spirometry in systemic sclerosis-associated interstitial lung disease: a pilot study. Rheumatology (Oxford), 2021, 60(5): 2467-2471.
28. Li J, Li X, Deng M, et al. Features and predictive value of 6-min walk test outcomes in interstitial lung disease: an observation study using wearable monitors. BMJ Open, 2022, 12(6): e055077.
29. Moor CC, Mostard RLM, Grutters JC, et al. Home monitoring in patients with idiopathic pulmonary fibrosis. A randomized controlled trial. Am J Respir Crit Care Med, 2020, 202(3): 393-401.
30. Attaway AH, Welch N, Yadav R, et al. Quantitative computed tomography assessment of pectoralis and erector spinae muscle area and disease severity in chronic obstructive pulmonary disease referred for lung volume reduction. COPD, 2021, 18(2): 191-200.
31. Y?lmaz ?ankaya B, Karaman A, et al. The association of silicosis severity with pectoralis major muscle and subcutaneous fat volumes and the pulmonary artery/aorta ratio evaluated by CT. Diagn Interv Radiol, 2021, 27(1): 37-41.
32. Tsang EW, Kwok H, Chan AKY, et al. Outcomes of community-based and home-based pulmonary rehabilitation for pneumoconiosis patients: a retrospective study. BMC Pulm Med, 2018, 18(1): 133.
33. 程樂霞, 李萍, 米正萍. 基于 Heider 平衡理論的遠程教育干預在塵肺病患者中的應用效果分析. 工業衛生與職業病, 2021, 47(2): 110-113.
34. 彭秋鳳, 何靜春, 李立宇, 等. 遠程指導運動呼吸訓練在穩定期Ⅱ期塵肺病患者中的實施效果觀察. 山東醫藥, 2022, 62(33): 64-67.
35. Layton AM, Irwin AM, Mihalik EC, et al. Telerehabilitation using fitness application in patients with severe cystic fibrosis awaiting lung transplant: a pilot study. Int J Telemed Appl, 2021, 2021: 6641853.
36. Dechman G, Aceron R, Beauchamp M, et al. Delivering pulmonary rehabilitation during the COVID-19 pandemic: a Canadian Thoracic Society position statement. Can J Resp Crit Care, 2020, 4(4): 232-235.
37. Geramita EM, DeVito Dabbs AJ, DiMartini AF, et al. Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial. Transplantation, 2020, 104(3): 640-651.
38. K?l?? L, Pehlivan E, Balc? A, et al. Effect of 8-week pulmonary rehabilitation program on dyspnea and functional capacity of patients on waiting list for lung transplantation. Turk Thorac J, 2020, 21(2): 110-115.
39. Wickerson L, Helm D, Gottesman C, et al. Telerehabilitation for lung transplant candidates and recipients during the COVID-19 pandemic: program evaluation. JMIR Mhealth Uhealth, 2021, 9(6): e28708.
40. Dowman L, Hill CJ, May A, et al. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev, 2021, 2(2): CD006322.
41. Cox NS, Dal Corso S, Hansen H, et al. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev, 2021, 1(1): CD013040.

Previous Article
Prediction of risk factors and progress in diagnosis and treatment of acute respiratory distress syndrome
Next Article
Research progress of irisin in acute kidney injury

West China Medical Journal

Application of remote home respiratory rehabilitation for pneumoconiosis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content